REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

I Vaxx Mktg Corporation (Philippines)

Main Activities: Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores
Full name: I Vaxx Mktg Corporation Profile Updated: January 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The subject is engaged with the retail sale of pharmaceutical products, medical supplies, cosmetics, and toilet articles. This includes the distribution of prescription and non-prescription medications, medical equipment and supplies, a variety of cosmetic products, and a range of toilet articles.

Headquarters
B27 L21 #379, Silam Road, Central Park Subd.
Davao City; Davao del Sur;

Contact Details: Purchase the I Vaxx Mktg Corporation report to view the information.

Basic Information
Financial Auditors:
Purchase the I Vaxx Mktg Corporation report to view the information.
Incorporation Date:
August 19, 2015
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Company Secretary;Member
Purchase this report to view the information.
Member
Purchase this report to view the information.
Member
Ownership Details
Purchase this report to view the information.
29%
Purchase this report to view the information.
28%
Purchase this report to view the information.
15%
Purchase this report to view the information.
15%
Purchase this report to view the information.
13%
Company Performance
Financial values in the chart are available after I Vaxx Mktg Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
7.12%▲
Total operating revenue
7.12%▲
Operating profit (EBIT)
-2.26%▼
EBITDA
-1.51%▼
Net Profit (Loss) for the Period
-2.26%▼
Total Assets
15.9%▲
Total Equity
6.21%▲
Operating Profit Margin (ROS)
-0.41%▼
Net Profit Margin
-0.41%▼
Return on Equity (ROE)
-0.64%▼
Quick Ratio
0.08%▲
Cash Ratio
-0.19%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo